We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Analyzing Samples Faster Than Ever Before
Blog

A typical drug compound library can easily be comprised of millions of compounds – managing, processing and analyzing these libraries takes both time and effort, as well as being costly. But what if it was possible to screen vast libraries in days, rather than weeks, or even months?

Read More

Center Set To Support the Delivery of Novel, High-quality Therapeutics
Blog

We recently spoke with Thermo Fisher Scientific's Eric Grumbach, to learn more about the opening of the company's new Pharma and BioPharma Center, located in Shanghai, China. The center is set to support the rapid delivery of novel and high-quality therapeutics by providing expertise in critical analytical techniques and specialized workflows.

Read More

Behind the Scenes of MRI-based Liver Disease Diagnostics
Blog

Early diagnosis of liver disease can be life-saving, particularly because the liver has an amazing capacity to regenerate – so it is possible to curb highly prevalent diseases such as fatty liver disease by making lifestyle changes. By taking advantage of magnetic resonance imaging (MRI), Perspectum Diagnostics are developing ways to improve diagnosis in the clinic and accelerate drug discovery.

Read More

Feeding the Microbiome: How MMTs Could Change the Landscape of Therapeutics
Blog

Technology Networks recently spoke with Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer at Kaleido Biosciences, to learn more about the development of Microbiome Metabolic Therapies (MMTs), and how Kaleido are advancing a pipeline of MMTs for a variety of disease indications.

Read More

Global Risk Reduction Approaches Put Pressure on PFAS Environmental Screening
Blog

Exposure to high levels of PFAS can be damaging to human health, and is associated with complications in reproduction, immune responses and some types of cancer. These issues, coupled with growing concerns about the impact of PFAS on the environment, mean that the detection and identification of PFAS has become a top priority for environmental testing laboratories worldwide.

Read More

Tackling Immune Dysregulation – A Key Driver of Disease
Blog

Immune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.

Read More

Detecting Sepsis Early
Blog

We recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.

Read More

Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
Blog

In this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.

Read More

Detecting Human and Cross-species Drug Toxicities With the Liver-Chip
Blog

Geraldine A. Hamilton, PhD, President and Chief Scientific Officer of Emulate Inc., shares her perspectives on the challenges of using animal toxicity models and discusses how these can translate to late-stage attrition in drug development. She also highlights the advantages of using “organ-on-chip” technologies for toxicity testing and delves into the company’s recent findings related to the ability to reproduce human and cross-species drug toxicities using a liver-chip

Read More

Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold
Blog

With constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.

Read More